Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.015 -6.52% 0.215 0.21 0.22 0.225 0.215 0.22 17,769,116 14:17:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 0.2 -2.6 -0.5 - 13

Microsaic Systems Share Discussion Threads

Showing 3926 to 3946 of 3950 messages
Chat Pages: 158  157  156  155  154  153  152  151  150  149  148  147  Older
DateSubjectAuthorDiscuss
22/7/2021
16:13
so come on - where exactly does your hatred of G Brandon come from ?
ragnarr
21/7/2021
19:48
As a matter of interest how much did you loose out of Alltracel ?
ragnarr
21/7/2021
13:45
Great news indeed, especially for GB's very very very close friends over at TP. A off the scale almost one billion shares can be exercised within the next two years at a give away 0.1p. This equates to an instant 1 million profit at today's rates. What with recent 2 million profit from the take over of Modern Water, one assumes its great work if you can get it. I suppose also worth mentioning the fact the Modern water deal also netted the chairman of that company and the CEO of deep verge a huge pay out. Don't make the mistake of thinking it was two different people, you couldn't write it if you had tried.
cocker
21/7/2021
13:22
https://www.genengnews.com/topics/bioprocessing/microsaic-systems-goes-real-time-with-pat/
ragnarr
09/7/2021
09:23
Morning my little troll friend - Its perfectly fine to point out negative issues but for you its just this obsession/hatred with G Brandon that undermines your posts by simply repeating the same point again and again and again and you will no doubt continue to repeat - you have just become white noise.Truth teller - sadly I think you actually believe that - reality you are just the entertainment.You never answered my question over on DVRG months ago - what are you hiding.
ragnarr
08/7/2021
15:44
Still taking it all so personally I see, and wasting hours of your life trolling MSYS and DVRG
ragnarr
08/7/2021
12:07
Troll, I prefer the truth teller. Today's facts or numbers as the Leprechaun loves so much, did you know Turner Poop are entitled to exercise almost a billion warrants at 0. 1p for services rendered. Who on God's earth would buy shares in this company when associates pockets are being lined with gold.
cocker
07/7/2021
16:57
Afternoon my little troll friend.
ragnarr
07/7/2021
15:34
WOW, that almost 600 % increase is still 50% below the previous years T/O, so hardly worth a mention. It's also only 20% of annual running costs let alone the huge losses this company is piling up year on year. Probably better to point out more relevant facts like15mill mrk cap which is ridiculous and has how many billion shares in issue, with the usual warrant festival to begin.
cocker
07/7/2021
15:22
Microsaic Systems sees revenues surge by 594% in 1H21https://www.voxmarkets.co.uk/articles/microsaic-systems-sees-revenues-surge-by-594-in-1h21--efd4640/
ragnarr
06/7/2021
10:27
Jones you need to do more homework my friend. GB took a huge part in the 0.1p heavily discounted placing here, as did his wife I believe. Although if my memory serves me right the funds were from shares she sold in Deep Verge that no one knew about until the market was informed. I'm sure it was all above board and an oversite on her behalf.
cocker
06/7/2021
09:42
The Chairman owns 140m shares, roughly 2.3%. Worth reading the Shareholders Circular before posting comments like this.
gjbrandon
06/7/2021
09:20
I wonder why the directors show so little confidence in this business ? Holding 1 million shares looks like a lot for the CFO, but at 0.26p, that works out at about £2600. I guess he might not see it as a potential rocket stock. The new chairman seems not to have bought any shares yet, whilst he holds £2.6m in Deep Verge, which is mentioned as a related party in the RNS today.
jonesj
06/7/2021
07:31
06/07/2021 7:00am UK Regulatory (RNS & others) Microsaic Systems (LSE:MSYS) Intraday Stock Chart Tuesday 6 July 2021 Click Here for more Microsaic Systems Charts. TIDMMSYS RNS Number : 2415E Microsaic Systems plc 06 July 2021 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) ("UK MAR"). 6 July 2021 Microsaic Systems plc ("Microsaic" or the "Company") Microsaic trading update for H1 2021 Unaudited revenues up 594% on H1 2020 and 52% on H1 2019, reflecting new business model Microsaic (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments is delighted to announce that a strategic change of business model early in 2021 has resulted in recovery of growth in revenues, increasing to GBP0.499m in H1 2021, significantly above H1 2020 and that of H1 2019, a pre-pandemic benchmark. First Half Highlights: -- Unaudited revenues of GBP0.499m o 594% increase over H1 2020 (GBP0.072m) and 52% over H1 2019 (GBP0.328m). -- January: transformative placing which raised GBP5.5m (gross), board changes and strategic shift away from independent development to a commercial strategy with external partners. -- Five key commercial hires to accelerate revenues on environmental detection of water contamination and in human health markets, delivering real-time on-site monitoring and data analytics with connected Internet of Things ("IoT"), AI and support services. -- March: commercial agreement with DeepVerge plc ("DeepVerge"; AIM: DVRG), through which Microsaic products and services are being deployed internationally in applications such as water monitoring of chemicals and pathogens, and in support of DeepVerge's rapidly growing Labskin division. -- May: initial shipments to a new Chinese partner to obtain a medical licence in China for real-time therapeutic monitoring of drugs with commercialisation (including service and reagents revenue sharing) expected in 2022. -- May: collaboration with Swansea University to combine real-time monitoring of environmental water using AI in determining the link between environmental chemical pollution and human health. -- June: further order from DeepVerge under the framework agreement Post Period Events: -- July: The world first demonstration of real-time monitoring of on-line production of biotherapeutic drugs such as vaccines and anti-cancer treatments using Process Analytical Technology within a Microsaic micro-engineered MS solution. Ongoing commercial developments -- Disruptive low-cost and mobile system to detect organic chemicals in water and wastewater adapted for in-field deployment. -- Detection of volatile contaminants in water, with product demonstration expected in H2 of this year. This significantly expands the reach of applications with mobile capability for environmental regulatory authorities. -- Multiple collaboration projects, including in-surgery cancer diagnostics, with the aim to secure commercial supply agreements with the potential to revolutionise surgical oncology interventions. Glenn Tracey, CEO of Microsaic Systems plc, commented: " I am thrilled to report this transformational performance for the first half of 2021, after the effects that the COVID-19 lockdown had on our customers, employees in 2020 and the financial strain this placed on the Company. The new commercial strategy of collaborating, partnering and revenue sharing has moved the Company away from equipment-only sales. We are now offering integrated real-time data analytics with AI alongside our mass spectroscopy hardware, providing complete solutions such as in-field environmental testing and on-site human diagnostics. The change of strategy and adjustment to a revenue sharing business model has demonstrated solid evidence of sales growth which is expected to continue into H2. Given the ongoing uncertainties over the effects of further waves of COVID-19 across multiple geographies, the Board remains cautious on short-term forecasting. Accordingly, we will consider whether it is appropriate to reinstate guidance to analysts after publication of the interim results, which is expected to take place during the autumn. However, prospects over the mid-term are looking more positive, with the encouraging first half results being more reflective of the Company's potential, and we look forward to our next scheduled performance update. " Related party transaction On 24 March 2021, the Company announced that it had entered into a non-exclusive Framework Services Agreement (the "Agreement") with DeepVerge. The multi-year Agreement provides for the supply by Microsaic to DeepVerge of miniaturised mass spectrometry equipment and services, across DeepVerge's sales, marketing, and distribution channels. The Agreement included an initial order of three units as well as a commitment to purchase further units in connection with the installation of pilot demonstration facilities at DeepVerge's York laboratories (together, the "Orders"). The Company has processed a further smaller purchase order from DeepVerge (the "Further Order") under the Agreement, supplying certain additional mass spectrometry equipment for quality and contamination detection in a range of markets including water and soil analysis. The value of the Further Order is approximately GBP72,000 and constitutes a related party transaction under Rule 13 of the AIM Rules. Additionally, Microsaic is loaning an additional item of equipment to DeepVerge for no consideration, to enable an early evaluation of certain technical aspects of its potential use. At the time of entering into the Agreement, the independent directors, being Glenn Tracey and Bevan Metcalf, considered, having consulted with the Company's nominated adviser, that the terms of the Agreement, were fair and reasonable insofar as the Company's shareholders are concerned. The independent directors also consider that the terms of the Further Order are consistent with the Agreement and with the terms of the initial Orders, and therefore they consider that the terms of the Further Order continue to be fair and reasonable insofar as shareholders are concerned.
david gruen
06/7/2021
07:23
Looks very positive here
cashistrash
05/7/2021
09:14
Sold a few here today and taken profit and put into Deepverge DVRG, think Microsaic will need more money in the future, have some left though. Info on Deepverge. The impact will be good in the long run for Microsaic...
onehanded
02/7/2021
16:33
Cheers, ragnarr - appreciate the info.
daveboy19
02/7/2021
16:19
Worth a read to understand the implications of todays newsHow to Improve Productivity and Lower Costs with Real-Time Technology at the Point-of-Needhttps://www.microsaic.com/news/how-to-improve-productivity-and-lower-costs-with-real-time-technology-at-the-point-of-need/
ragnarr
02/7/2021
15:20
Nice one. Just wish these RNS's contained some figures for us long-suffering PI's.
daveboy19
02/7/2021
14:01
I asked my son who is studying Chemistry at Oxford and he says that real time spectrometry is an amazing achievement - usually takes ages and lots of different processes so it should significantly speed up the development of new drugs.
janhar
02/7/2021
10:29
Riveting price action to back up today's RNS. All in all, back to sleep zzzz. See you all in 2024.
daveboy19
Chat Pages: 158  157  156  155  154  153  152  151  150  149  148  147  Older
ADVFN Advertorial
Your Recent History
LSE
MSYS
Microsaic ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 15:16:39